Petros Pharma reduces President Boctor's base salary to $280K, sets Dec 31 termination

Petros Pharmaceuticals, Inc.

Base salary cut from $350K to $280K effective Oct 16, 2024.
Employment termination date set to Dec 31, 2024; at-will status continues.
Boctor now permitted to engage in other consulting/employment activities if no conflict.
Amendment approved by Director Josh Silverman.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.